-transparent.png){kind=logo}
Pulmonary function tests were performed before and at different times after 250 mg L-Dopa in 12 patients with Parkinson's disease (PD). Six were de-novo patients, the other six patients had been taking L-Dopa over different periods. All patients had an abnormal basal flow-volume loop, which significantly improved only in de-novo patients. This improvement occurred early and was independent on improvement of neurological symptoms. The effect of L-Dopa on pulmonary function could be a useful test in differentiating PD from related extrapyramidal syndromes.
Related Publications
V Brescia Morra, and
M Polverino, and
G De Luca, and
P Landi, and
A Galdi, and
G Campanella
July 1989,
Chest,
V Brescia Morra, and
M Polverino, and
G De Luca, and
P Landi, and
A Galdi, and
G Campanella
August 1989,
Clinical neuropharmacology,
V Brescia Morra, and
M Polverino, and
G De Luca, and
P Landi, and
A Galdi, and
G Campanella
January 2018,
Journal of communication disorders,
V Brescia Morra, and
M Polverino, and
G De Luca, and
P Landi, and
A Galdi, and
G Campanella
June 1995,
Anaesthesia and intensive care,
V Brescia Morra, and
M Polverino, and
G De Luca, and
P Landi, and
A Galdi, and
G Campanella
February 1996,
Anaesthesia and intensive care,
V Brescia Morra, and
M Polverino, and
G De Luca, and
P Landi, and
A Galdi, and
G Campanella
December 2009,
Journal of clinical pharmacy and therapeutics,
V Brescia Morra, and
M Polverino, and
G De Luca, and
P Landi, and
A Galdi, and
G Campanella
July 2016,
Parkinsonism & related disorders,
V Brescia Morra, and
M Polverino, and
G De Luca, and
P Landi, and
A Galdi, and
G Campanella
January 1994,
Lung,
V Brescia Morra, and
M Polverino, and
G De Luca, and
P Landi, and
A Galdi, and
G Campanella
January 2013,
European neurology,
V Brescia Morra, and
M Polverino, and
G De Luca, and
P Landi, and
A Galdi, and
G Campanella
February 1994,
Journal of neurology, neurosurgery, and psychiatry,
